Last reviewed · How we verify

hydrocodone, acetaminophen and ibuprofen

Albany Medical College · FDA-approved active Small molecule

This combination drug provides pain relief through three complementary mechanisms: hydrocodone acts as an opioid agonist, acetaminophen inhibits prostaglandin synthesis, and ibuprofen inhibits cyclooxygenase enzymes.

This combination drug provides pain relief through three complementary mechanisms: hydrocodone acts as an opioid agonist, acetaminophen inhibits prostaglandin synthesis, and ibuprofen inhibits cyclooxygenase enzymes. Used for Moderate to moderately severe pain.

At a glance

Generic namehydrocodone, acetaminophen and ibuprofen
Also known asno other intervention names applicable
SponsorAlbany Medical College
Drug classOpioid analgesic combination
TargetOpioid receptors (hydrocodone); COX-1/COX-2 (ibuprofen); unclear (acetaminophen)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Hydrocodone binds to opioid receptors in the central nervous system to reduce pain perception. Acetaminophen and ibuprofen are both analgesics and antipyretics that work through different pathways—acetaminophen's exact mechanism is not fully understood but involves central nervous system effects, while ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain by inhibiting COX-1 and COX-2 enzymes. The combination provides synergistic pain relief for moderate to moderately severe pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: